Free Trial

LivaNova (LIVN) Competitors

LivaNova logo
$43.66 -1.22 (-2.72%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$43.66 0.00 (0.00%)
As of 05/21/2025 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LIVN vs. STVN, GKOS, NARI, INSP, IRTC, BLCO, TMDX, SLNO, NVST, and PRCT

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

LivaNova vs.

LivaNova (NASDAQ:LIVN) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking, risk, valuation and institutional ownership.

Stevanato Group has a net margin of 10.47% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova1.91% 13.81% 7.07%
Stevanato Group 10.47%9.86%5.79%

97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 0.7% of Stevanato Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

LivaNova has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500.

LivaNova received 378 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 69.80% of users gave LivaNova an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
LivaNovaOutperform Votes
409
69.80%
Underperform Votes
177
30.20%
Stevanato GroupOutperform Votes
31
63.27%
Underperform Votes
18
36.73%

Stevanato Group has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.28B1.87$17.55M-$4.09-10.67
Stevanato Group$1.12B6.46$157.62M$0.5147.06

In the previous week, LivaNova had 10 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for LivaNova and 7 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.44 beat LivaNova's score of 1.33 indicating that Stevanato Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
12 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova currently has a consensus target price of $59.29, indicating a potential upside of 35.79%. Given LivaNova's stronger consensus rating and higher probable upside, analysts clearly believe LivaNova is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.00
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86

Summary

LivaNova beats Stevanato Group on 12 of the 18 factors compared between the two stocks.

Get LivaNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.38B$3.26B$5.35B$8.38B
Dividend YieldN/A1.73%5.22%4.10%
P/E Ratio103.9516.6026.8419.71
Price / Sales1.8785.43391.39116.98
Price / Cash11.1544.0938.2534.62
Price / Book1.843.736.794.50
Net Income$17.55M$94.03M$3.23B$248.18M
7 Day Performance0.25%2.20%4.07%1.14%
1 Month Performance26.15%25.87%12.52%15.18%
1 Year Performance-27.89%-13.57%16.83%6.55%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIVN
LivaNova
3.7979 of 5 stars
$43.66
-2.7%
$59.29
+35.8%
-27.9%$2.38B$1.28B103.952,900Positive News
Analyst Upgrade
STVN
Stevanato Group
1.2885 of 5 stars
€23.64
-1.5%
N/A+24.6%$7.16B$1.10B50.304,650Positive News
GKOS
Glaukos
4.6206 of 5 stars
$94.57
+5.1%
$134.67
+42.4%
-12.5%$5.40B$404.52M-32.95780Positive News
NARI
Inari Medical
0.5708 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
INSP
Inspire Medical Systems
4.672 of 5 stars
$156.54
+3.5%
$211.91
+35.4%
-4.0%$4.62B$840.11M90.49760Positive News
Gap Up
IRTC
iRhythm Technologies
1.2686 of 5 stars
$137.80
+0.1%
$128.55
-6.7%
+52.9%$4.40B$618.59M-37.861,790Positive News
BLCO
Bausch + Lomb
4.1389 of 5 stars
$11.91
+5.6%
$15.50
+30.2%
-22.8%$4.21B$4.83B-13.0812,500Gap Up
TMDX
TransMedics Group
1.4381 of 5 stars
$118.73
+6.5%
$126.70
+6.7%
-12.4%$4.02B$488.23M126.31210Positive News
SLNO
Soleno Therapeutics
4.8514 of 5 stars
$76.70
-0.1%
$106.78
+39.2%
+65.6%$3.87BN/A-23.1030News Coverage
Positive News
NVST
Envista
4.1759 of 5 stars
$18.56
+5.5%
$20.08
+8.2%
-9.2%$3.15B$2.50B-2.8612,700Positive News
Gap Up
PRCT
PROCEPT BioRobotics
2.9275 of 5 stars
$54.44
+2.5%
$90.00
+65.3%
-17.6%$3.01B$249.12M-27.92430Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:LIVN) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners